Chemoocclusion vs chemoperfusion for treatment of advanced hepatocellular carcinoma: A randomised trial

European Journal of Surgical Oncology

Volumn 32, Issue 2, 2006, Pages 201-207

  Kirchhoff, T D ^a   Rudolph, K L ^a   Layer, G ^b   Chavan, A ^c   Greten, T F ^a   Rosenthal, H ^a   Kubicka, S ^a   Galanski, M ^a   Manns, M P ^a   Schild, H ^d   Gallkowski, U ^e,f  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

^c KLINIKUM OLDENBURG   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e DRK Krankenhaus Neuwied   (Germany)

^f German Working Group for Regional Chemotherapy (ART)   (Germany)

Author keywords

Degradable starch microspheres; HCC; Randomised trial; Transarterial

Indexed keywords

CISPLATIN; DOXORUBICIN; MICROSPHERE; STARCH;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHOLECYSTITIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GENDER; HAIR LOSS; HUMAN; LEUKOPENIA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PERFUSION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; STARCH; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 32944458855     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.11.003     Document Type: Article

References (35)

1. T. Kato R. Nemoto H. Mori M. Takahashi Y. Tamakawa M. Harada Arterial chemoemboliation with microencapsulated anticancer drug. An approach to selective cancer chemotherapy with sustained effects JAMA 245 1981 1123-1127
2. T. Tancredi P.A. McCuskey Z. Kan S. Wallace Changes in rat liver microcirculation after experimental hepatic arterial embolization: comparison of different embolic agents Radiology 211 1999 177-181
3. J.L. Raoul D. Heresbach J.F. Bretagne D.B. Ferrer R. Duvauferrier P. Bourguet Chemoembolization of hepatocellular carcinoma. A study of the biodistribution and pharmacokinetics of doxorubicin Cancer 70 1992 585-590
4. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma N Engl J Med 332 1995 1256-1261
5. J. Bruix J.M. Llovet A. Castells X. Montaua C. Bru M.C. Ayuso Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution Hepatology 27 1998 1578-1583
6. G. Pelletier M. Ducreux F. Gay M. Luboinski M. Hagege T. Dao Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial J Hepatol 29 1998 129-134
7. C. Tellez A.B. Benson III M.T. Lyster M. Talamonti J. Shaw M.A. Braun Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature Cancer 82 1998 1250-1259
8. C. Cammà F. Schepis A. Orlando M. Albanese L. Shahied F. Trevisani Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials Radiology 224 2002 47-54
9. P. Mathurin O. Rixe N. Carbonell B. Bernard P. Cluzel M.F. Berlin Review article. Overview of medical treatments in unresectable hepatocellular carcinoma-an impossible meta-analysis? Aliment Pharmacol Ther 12 1998 111-126
10. J.M. Llovet M.I. Real X. Montana R. Planas S. Coll J. Aponte Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma. A randomised controlled trial Lancet 359 2002 1734-1739
11. C.M. Lo H. Ngan W.K. Tso C.L. Liu CM. Lam RT. Poon Randomised controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164-1171
12. M. Llovet J. Bruix Systematic review of randomised trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology 37 2003 429-442
13. L. Lladó J. Virgili J. Figueras C. Valls J. Dominguez A. Rafecas A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization Cancer 88 2000 50-57
14. A.O. Chan M.F. Yuen C.K. Hui W.K. Tso C.L. Lai A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma Cancer 94 2002 1747-1752
15. K. Taniguchi K. Nakata Y. Kato Y. Sato K. Hamasaki S. Tsuruta Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Analysis of prognostic factors Cancer 73 1994 1341-1345
16. L. Belli G. Magistretti G.P. Puricelli G. Damiani E. Colombo G.P. Cornalba Arteritis following intra-arterial chemotherapy for liver tumors Eur Radiol 7 1997 323-326
17. B. Lindell K.F. Aronsen B. Nosslin U. Rothman Studies in pharmacokinetics and tolerance of substances temporarily retained in the liver by microsphere embolization Ann Surg 187 1978 95-99
18. S. Dakhil W. Ensminger K. Cho J. Niederhuber K. Doan R. Wheeler Improved regional selectivity of hepatic arterial BCNU with degradable microspheres Cancer 50 1982 631-635
19. T. Taguchi Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres Clin Pharmacokinet 26 1994 275-291
20. L. Hakansson A. Hakansson O. Morales L. Thorelius T. Warfving Spherex (degradable starch microspheres) chemo-occlusion-enhancement of tumor drug concentration and therapeutic efficacy: An overview Semin Oncol 24 1997 S6-100-S6-109
21. J. Furuse H. Ishii M. Satake H. Onaya H. Nose S. Mikami Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma Am J Clin Oncol 26 2003 159-164
22. D. Civalleri J.C. Pector L. Hakansson J.P. Arnaud N. Duez M. Buyse Treatment of patients with liver metastases form colorectal cancer by chemo-occlusion with degradable starch microspheres Br J Surg 81 1994 1338-1341
23. B.I. Carr A. Zajko K. Bron P. Orons J. Sammon R. Baron Phase II study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: Interim analysis Semin Oncol 24 1997 S6-97-S6-99
24. C.J. Johansson Pharmacokinetic rationale for chemotherapeutic drugs combined with intra-arterial degradable starch microspheres (Spherex) Clin Pharmacokinet 31 1996 231-240
25. B.I. Carr S. Iwatsuki T.E. Starzl R. Selby J. Madariaga Regional cancer chemotherapy for advanced stage hepatocellular carcinoma J Surg Oncol Suppl 3 1993 100-103
26. C.J. Johansson H. Teder L. Gronquist P.O. Gunnarson Hepatic intra-arterial administration of doxorubicin and degradable starch microspheres. A pharmacokinetic study in the rat Acta Oncol 33 1994 39-42
27. M. Kajanti P. Rissanen P. Virkkunen K. Franssila M. Mantyla Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma. A phase II study Cancer 58 1986 2386-2388
28. J.M. Llovet J. Bustamante A. Castells R. Vilana MC. Ayuso M. Sala Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 1999 62-67
29. J.S. Yu K.W. Kim M.G. Jeong D.H. Lee M.S. Park S.W. Yoon Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy Cardiovasc Intervent Radiol 25 2002 270-274
30. T. deBaere P. Taourel J.M. Tubiana V. Kuoch M. Ducreux J. Lumbrose Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow Radiology 212 1999 665-668
31. W.Y. Lau T.W. Leung S.K. Ho M. Chan D. Machin J. Lau Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial Lancet 353 1999 797-801
32. T.J. Vogl M. Trapp H. Schroeder M. Mack A. Schuster J. Schmitt Transarterial chemoembolization for hepatocellular carcinoma: Volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center Radiology 214 2000 349-357
33. Y. Kigami H. Kobayashi S. Umeoka T. Emoto K. Akuta Early effect of intra-arterial chemotherapy combined with degradable stach microspheres for malignant hepatic tumors Gan To Kagaku Ryoho 30 2003 81-87
34. S. Okada Transcatheter arterial embolization for advanced hepatocellular carcinoma: The controversy continues Hepatology 27 1998 1743-1744
35. T. Kanematsu K. Inokuchi K. Sugimachi T. Furuta T. Sonoda S. Tamura Selective effects of lipiodolized antitumor agents J Surg Oncol 25 1984 218-226